Claritin Ripple Effects: Cardinal Manufacturing, Distribution Show OTC Impact
The ripple effects from the OTC switch of Claritin will include a short-term margin challenge for Cardinal Health
You may also be interested in...
Urticaria indications for future antihistamine Rx-to-OTC switches should be broadened to include acute hives in order to reflect actual patient use, an FDA advisory committee recommended
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials